HCG Hospital Bangalore Embraces a new Technology for accurate Breast Cancer Diagnosis

Bangalore, November 18, 2015: HealthCare Global Enterprises Ltd (HCG),a specialist in cancer care has introduced revolutionary technology, Vacuum Assisted Breast Biopsy (VABB), for a more accurate diagnosis &treatment of breast cancer in Bangalore. This technology ensures very high accuracy & scar free detection of a breast cancer tumor.

As per IARC (WHO) breast cancer constituted 22.2% of cancer in 2008 which increased to 27% in 2012.Of the 300,000 cancer cases treated/managed by oncologists in India, more than 10% are breast cancers out of which one third are new cases. With women generally presenting late for diagnosis, more than 60% of patients present at the locally advanced stages of breast cancer and the mortality associated with it is as high as 35%.

However, with increasing awareness, more women are going for regular breast screenings & mammography and if found at a high risk of the disease they are reaching out to the new state of the art hospitals across major Indian cities which now have the latest and the most accurate modalities of testing & imaging.

Dr. Sudhakar, who is an integral part the Radiology Department at the HCG hospital , Bangalore and is one of the most respected breast imaging and Intervention Radiologist in South-India, shares his views on this new platform acquired by his institute “As we have digital mammography and advanced ultrasound scan, small lesions are possible to be detected well before it actually presents. It was difficult to access to such small lesion through traditional core Biopsy, however with our new vacuum core Biopsy system , makes it easy to extract large volume of tissue, which also helps us diagnose hormone receptor & conduct Genomic studies. We can excise Fibroadenomas in young age with symptoms or family history. This daycare procedure is safe, cost effective and scar-less”

These new technologies use very sensitive techniques and can pick up abnormalities as small as 3-5mm in the breast; however the issue in India was the unavailability of means of sampling these cases found at early stages of the diseases and then to understand their nature as cancerous or non-cancerous.

With the groundbreaking Vacuum Assisted Breast Biopsy Technology, the biopsy for these small lesions can now be performed under the mammographic, stereotactic and ultrasound guidance. Precise guidance helps the doctor to site the abnormality more accurately and the procedure requires only a local anesthesia, reducing the whole procedure to a comfortable 45 minutes. The procedure involves a single needle insertion with vacuum pressure under the guidance of chosen imaging modality.

Without withdrawing and reinserting the needle, multiple samples can be collected, which are larger in size than a conventional needle biopsy procedure &larger samples eventually increase the accuracy of the diagnosis and better treatment protocols.

With awareness on regular breast screenings across all groups in India on the rise and these high technology products being adopted by leading healthcare institutions like the HCG Group in Bangalore and other hospitals across India, India is surely the next leading destination for world class healthcare solutions and patient care.
Corporate Comm India(CCI Newswire)